MarketCap
Facebook
X
TelegramAlexion Pharmaceuticals, Inc. ROE Ratio 2011-2026 | ALXN
Annual ROE Ratio Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 5.18 | 21.33 | 0.85 | 4.98 | 4.59 | 1.75 | 19.89 | 10.62 | 12.93 | 15.45 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.33 | 0.85 | 9.76 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
6.05 | $ 20.29 | -1.98 % | $ 2.56 B |  USA |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
-20.19 | $ 0.8 | -5.29 % | $ 4.36 M |  China |
 |
Axsome Therapeutics
AXSM
|
-207.46 | $ 166.62 | 0.14 % | $ 8.29 B | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | China |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
-15.14 | $ 3.76 | -1.7 % | $ 1.12 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
10.1 | $ 8.45 | -3.26 % | $ 1.38 B | Britain |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
-98.61 | $ 25.77 | -4.06 % | $ 690 M | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | Canada |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Codexis
CDXS
|
-97.53 | $ 0.97 | -5.15 % | $ 71.2 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
160.57 | $ 3.15 | -5.69 % | $ 1.13 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-34.6 | $ 28.45 | -2.57 % | $ 1.65 B | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
3.1 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-51.75 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
-26.25 | $ 3.65 | -3.95 % | $ 116 M | France |
 |
Alector
ALEC
|
-466.34 | $ 2.1 | -5.2 % | $ 216 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
-115.61 | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
-76.97 | $ 4.16 | -0.12 % | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
473.41 | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-40.09 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
22.46 | $ 23.99 | 0.46 % | $ 2.93 B | USA |
 |
Amarin Corporation plc
AMRN
|
-8.45 | $ 13.89 | -0.32 % | $ 5.76 B |  Irlanda |
 |
AbbVie
ABBV
|
-55.54 | $ 231.88 | -1.0 % | $ 410 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
-22.46 | - | - | $ 8.14 B | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
AIM ImmunoTech
AIM
|
-50.55 | $ 0.71 | -8.96 % | $ 34.1 M | USA |